The University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health are partnering on cancer center facilities in southeastern Louisiana.
Ochsner becomes one of seven MD Anderson partners in the country and the only one in Louisiana. Patients at Ochsner MD Anderson Cancer Center in southeastern Louisiana receive care based on the same protocols and practice standards provided at MD Anderson in Houston, and benefit from integration with its clinicians and researchers. MD Anderson conducts one of the world’s largest clinical trials programs, offering more than 1,600 clinical trials covering prevention, diagnosis, treatment and survivorship.
Ochsner MD Anderson experts adhere to the philosophy, process and guidelines of MD Anderson’s clinical leadership, and they provide a full range of multidisciplinary care options, including medical oncology, surgery and radiation.
“As the state’s leader in cancer care, we’re proud to partner with one of the global leaders in cancer care to provide a full continuum of services close to home for our patients,” said Mike Hulefeld, president and chief operating officer of Ochsner Health, in a statement. “Beyond MD Anderson’s accolades and top national rankings, its clinicians and researchers advance innovative therapies through clinical trials several years before they become standard practice. Now, our patients will benefit from this expanded breadth of experience and therapies in Louisiana.”
In this first phase, Ochsner MD Anderson facilities are located in the New Orleans area, Baton Rouge and Covington. They include:
• The Gayle and Tom Benson Cancer Center at Ochsner Medical Center
• Ochsner Medical Center - Kenner
• Ochsner Medical Center - West Bank Campus
• Ochsner Baptist - A Campus of Ochsner Medical Center
• Ochsner Cancer Center - Baton Rouge
• Ochsner Medical Complex - The Grove
• St. Tammany Cancer Center - A Campus of Ochsner Medical Center
Ochsner and MD Anderson will work together to certify additional sites in the future. Cancer patients throughout the entire Ochsner system will continue to receive high-quality clinical care and benefit from the largest clinical trials network in Louisiana and Mississippi, Ochsner said.
“As part of our ongoing commitment to providing world-renowned cancer care close to home, Ochsner is thrilled to join forces with MD Anderson to offer groundbreaking research and innovative therapies not found anywhere else in our region,” said Brian Moore, M.D., medical director of Ochsner MD Anderson Cancer Center, in a statement. “Our patients can be confident that they will receive an enhanced level of comprehensive cancer care through this partnership. Each member of our select team of cancer physicians has been certified by MD Anderson to clinically practice as part of the co-branded Ochsner MD Anderson cancer program, and appointed physicians will become adjunct members of MD Anderson faculty.”
